Novartis has submitted its meningococcal vaccine Bexsero to European regulators for marketing approval. If approved the drug will be the …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

